The NIH has radically reduced the time for the public to comment on exclusive licenses
KEI Briefing Note 2023:1
August 11, 2023
James Love, Marshall Pentes and Luis Gil Abinader
https://keionline.org/briefingnotes/kei-bn-2023-1.pdf
From the briefing note:
